Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancers|September 23, 2022
The Evolving Landscape of Immunotherapy in Locally Advanced Rectal Cancer PatientsMarco Maria Germani, Martina Carullo, Alessandra Boccaccino, et al.
Cancers|October 27, 2022
Immune-Checkpoint Inhibitors (ICIs) in Metastatic Colorectal Cancer (mCRC) Patients beyond Microsatellite InstabilityBeatrice Borelli, Carlotta Antoniotti, Martina Carullo, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2022
Treatments after second progression in metastatic colorectal cancer: A pooled analysis of the TRIBE and TRIBE2 studiesDaniele Rossini, Marco M Germani, Sara Lonardi, et al.
Cancers|June 10, 2023
Irinotecan- vs. Oxaliplatin-Based Doublets in KRASVincenzo Formica, Cristina Morelli, Veronica Conca, et al.
British Journal of Cancer|July 13, 2021
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studiesRoberto Moretto, Daniele Rossini, Veronica Conca, et al.
Cancers|November 25, 2023
Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 StudiesValentina Fanotto, Daniele Rossini, Mariaelena Casagrande, et al.
Future Oncology (London, England)|August 14, 2023
The prognostic value of radiomic features in liver-limited metastatic colorectal cancer patients from the TRIBE2 studyFederica Marmorino, Lorenzo Faggioni, Daniele Rossini, et al.
Clinical Colorectal Cancer|August 8, 2021
Rationale and Study Design of the PARERE Trial: Randomized phase II Study of Panitumumab Re-Treatment Followed by Regorafenib Versus the Reverse Sequence in RAS and BRAF Wild-Type Chemo-Refractory Metastatic Colorectal Cancer PatientsRoberto Moretto, Daniele Rossini, Iolanda Capone, et al.
Tumori|January 7, 2023
TK-1, TP, Ang-2, and Tie-2 mRNA expression in plasma-derived microvesicles of chemo-refractory metastatic colorectal cancer patientsBeatrice Borelli, Stefania Crucitta, Alessandra Boccaccino, et al.
Clinical Colorectal Cancer|March 19, 2022
Prognostic and Predictive Role of Body Mass Index (BMI) in Metastatic Colorectal Cancer (mCRC): A Pooled Analisys of Tribe and Tribe-2 Studies by GONOEmanuela Dell'Aquila, Daniele Rossini, Alessandro Galletti, et al.
Pageof 4